Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy
Authors:
- 4 February 2015
- journal article
- Published by Springer Nature in Leukemia
- Vol. 29 (8) , 1779-1780
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact on Outcome in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2015
- Prediction Of CR On Reinduction In Patients With Newly Diagnosed Acute Myeloid Leukemia Given Intensive Induction Regimens: A Report From SWOG and Cleveland ClinicBlood, 2013
- Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemiaLeukemia, 2013
- The Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact On Outcome in Acute Myeloid LeukemiaBlood, 2012
- Acute Myeloid LeukemiaJournal of the National Comprehensive Cancer Network, 2012
- Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experienceBlood, 2010
- Blood counts at time of complete remission provide additional independent prognostic information in acute myeloid leukemiaLeukemia Research, 2008
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB.2000
- Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEBBlood, 2000